BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

656 related articles for article (PubMed ID: 1689216)

  • 1. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site.
    Elices MJ; Osborn L; Takada Y; Crouse C; Luhowskyj S; Hemler ME; Lobb RR
    Cell; 1990 Feb; 60(4):577-84. PubMed ID: 1689216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte adhesion through very late antigen 4: evidence for a novel binding site in the alternatively spliced domain of vascular cell adhesion molecule 1 and an additional alpha 4 integrin counter-receptor on stimulated endothelium.
    Vonderheide RH; Springer TA
    J Exp Med; 1992 Jun; 175(6):1433-42. PubMed ID: 1375259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A monoclonal antibody to beta 1 integrin (CD29) stimulates VLA-dependent adherence of leukocytes to human umbilical vein endothelial cells and matrix components.
    Kovach NL; Carlos TM; Yee E; Harlan JM
    J Cell Biol; 1992 Jan; 116(2):499-509. PubMed ID: 1370496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-receptor occupancy events in leukocytes during beta 1 integrin-ligand interactions.
    Sánchez-Mateos P; Arroyo AG; Balboa MA; Sánchez-Madrid F
    Eur J Immunol; 1993 Oct; 23(10):2642-8. PubMed ID: 7691611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential regulation of alpha 4 beta 1 and alpha 5 beta 1 integrin avidity by CC chemokines in monocytes: implications for transendothelial chemotaxis.
    Weber C; Alon R; Moser B; Springer TA
    J Cell Biol; 1996 Aug; 134(4):1063-73. PubMed ID: 8769427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation dependent and independent VLA-4 binding sites on vascular cell adhesion molecule-1.
    Needham LA; Van Dijk S; Pigott R; Edwards RM; Shepherd M; Hemingway I; Jack L; Clements JM
    Cell Adhes Commun; 1994 Jun; 2(2):87-99. PubMed ID: 7521763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of third N-terminal domain of VCAM-1.
    Webb DL; Marlor CW; Conrad PJ; Barkowski-Clark S; Blue ML
    Biochem Biophys Res Commun; 1993 Dec; 197(2):674-81. PubMed ID: 7505573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated endothelium binds lymphocytes through a novel binding site in the alternately spliced domain of vascular cell adhesion molecule-1.
    Osborn L; Vassallo C; Benjamin CD
    J Exp Med; 1992 Jul; 176(1):99-107. PubMed ID: 1377228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular cell adhesion molecule (VCAM)-Ig fusion protein defines distinct affinity states of the very late antigen-4 (VLA-4) receptor.
    Jakubowski A; Rosa MD; Bixler S; Lobb R; Burkly LC
    Cell Adhes Commun; 1995 May; 3(2):131-42. PubMed ID: 7583006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of VLA-4 integrin by resident and peripheral blood B lymphocytes. Acquisition of functionally active alpha 4 beta 1-fibronectin receptors upon B cell activation.
    Postigo AA; Pulido R; Campanero MR; Acevedo A; García-Pardo A; Corbi AL; Sanchez-Madrid F; De Landazuri MO
    Eur J Immunol; 1991 Oct; 21(10):2437-45. PubMed ID: 1833203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple activation states of VLA-4. Mechanistic differences between adhesion to CS1/fibronectin and to vascular cell adhesion molecule-1.
    Masumoto A; Hemler ME
    J Biol Chem; 1993 Jan; 268(1):228-34. PubMed ID: 7677996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of vascular cell adhesion molecule-1 and fibronectin connecting segment-1 in monocyte rolling and adhesion on early atherosclerotic lesions.
    Huo Y; Hafezi-Moghadam A; Ley K
    Circ Res; 2000 Jul; 87(2):153-9. PubMed ID: 10904000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional evidence for three distinct and independently inhibitable adhesion activities mediated by the human integrin VLA-4. Correlation with distinct alpha 4 epitopes.
    Pulido R; Elices MJ; Campanero MR; Osborn L; Schiffer S; García-Pardo A; Lobb R; Hemler ME; Sánchez-Madrid F
    J Biol Chem; 1991 Jun; 266(16):10241-5. PubMed ID: 1709929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ICAM-3 regulates lymphocyte morphology and integrin-mediated T cell interaction with endothelial cell and extracellular matrix ligands.
    Campanero MR; Sánchez-Mateos P; del Pozo MA; Sánchez-Madrid F
    J Cell Biol; 1994 Nov; 127(3):867-78. PubMed ID: 7525599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VLA-4-dependent adhesion activities of U937 cells and guinea pig bronchoalveolar lavage leukocytes.
    Monshizadegan DA; Holloway DA; Torrente JM; Yednock T; Fritz L; Sturm RJ
    Agents Actions; 1993; 39 Spec No():C177-9. PubMed ID: 8273561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human natural killer cells express VLA-4 and VLA-5, which mediate their adhesion to fibronectin.
    Gismondi A; Morrone S; Humphries MJ; Piccoli M; Frati L; Santoni A
    J Immunol; 1991 Jan; 146(1):384-92. PubMed ID: 1701798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A region of the integrin VLA alpha 4 subunit involved in homotypic cell aggregation and in fibronectin but not vascular cell adhesion molecule-1 binding.
    Muñoz M; Serrador J; Sánchez-Madrid F; Teixidó J
    J Biol Chem; 1996 Feb; 271(5):2696-702. PubMed ID: 8576243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adhesion molecules from the LFA-1/ICAM-1,3 and VLA-4/VCAM-1 pathways on T lymphocytes and vascular endothelium in Graves' and Hashimoto's thyroid glands.
    Marazuela M; Postigo AA; Acevedo A; Díaz-González F; Sanchez-Madrid F; de Landázuri MO
    Eur J Immunol; 1994 Oct; 24(10):2483-90. PubMed ID: 7523142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VLA-4 integrin mediates lymphocyte migration on the inducible endothelial cell ligand VCAM-1 and the extracellular matrix ligand fibronectin.
    Chan PY; Aruffo A
    J Biol Chem; 1993 Nov; 268(33):24655-64. PubMed ID: 7693704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of an SJL T cell clone specific for myelin basic protein to SJL brain microvessel endothelial cells is inhibited by anti-VLA-4 or its ligand, anti-vascular cell adhesion molecule 1 antibody.
    Tanaka M; Sato A; Makino M; Tabira T
    J Neuroimmunol; 1993 Jul; 46(1-2):253-7. PubMed ID: 7689592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.